Please provide your email address to receive an email when new articles are posted on . Cutaneous staging was the only significant predictive variable of disease-specific survival in patients with ...

Cutaneous T cell lymphomas (CTCL) represent a heterogeneous group of T-cell malignancies that manifest primarily in the skin. By far the most common variant of CTCL is mycosis fungoides and its ...

In a recent clinical letter published by the Brazilian Society of Dermatology, researchers highlight the potential role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in ...

Mycosis fungoides is a type of cutaneous T-cell lymphoma, a cancer caused by abnormal proliferation of a type of white blood cells called T lymphocytes or T-cells and their infiltration into the skin.

Figure 1: Recurrent alterations in T cell survival and activation pathways in mycosis fungoides and Sézary syndrome. Figure 2: Mycosis fungoides and Sézary syndrome are characterized by recurrent ...

We identified 11 patients with CD10(+) cutaneous T-cell lymphoma by flow cytometry. All cases were CD4(+) and CD8(−). Three patients had extensive lymphadenopathy, systemic symptoms and an aggressive ...

A 68-year-old man presented to primary care with a rash consisting of polycyclic (overlapping circles) erythematous scaly papules and plaques with raised borders (Figure 1A) that was localized to his ...

Q: Which doctor treats mycosis fungoides? A: Mycosis fungoides is treated by a team of doctors which includes a dermatologist and an oncologist. A: In general, mycosis fungoides is considered a ...

First English-language case study shows resolution of lesions with 308-nm Excimer laser in rare mycosis fungoides (MF) subtype, poikilodermatous mycosis fungiodes (pMF), underscoring the Company’s ...

GALASHIELS & MARLOW, & BIRMINGHAM, United Kingdom--(BUSINESS WIRE)--Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global ...